e-learning
resources
Munich 2006
Sunday 03.09.2006
New developments in the treatment and management of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improvement in asthma control by using leukotriene receptor antagonists: results of an experience-based report in Swiss medical practice
J. D. Leuppi, C. Steurer-Stey, J. Wildhaber, F. Spertini (Basel, Zürich, Lausanne, Switzerland)
Source:
Annual Congress 2006 - New developments in the treatment and management of asthma
Session:
New developments in the treatment and management of asthma
Session type:
Oral Presentation
Number:
778
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. D. Leuppi, C. Steurer-Stey, J. Wildhaber, F. Spertini (Basel, Zürich, Lausanne, Switzerland). Improvement in asthma control by using leukotriene receptor antagonists: results of an experience-based report in Swiss medical practice. Eur Respir J 2006; 28: Suppl. 50, 778
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006
Early life origins of adult lung function
Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function
Year: 2006
Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations
Source: Eur Respir J 2012; 39: 290-296
Year: 2012
Awarding of the Occupation and Epidemiology Best Papers
Source: Annual Congress 2007 - Lunchtime programme: meet the Awardees and the Young Investigators of the Occupation and Epidemiology Assembly
Year: 2007
The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
Evidence for the onset of COPD in childhood, and the role of genetics
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
Source: Eur Respir J 2003; 21: 123-128
Year: 2003
Application and interpretation in RCT's
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Assessment of disease control in smokers and non-smokers with asthma in Switzerland: results of an experience-based report in medical practice
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Annual decline in forced expiratory volume and airways inflammatory cells, mediators in general population based sample.
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics
Source: Eur Respir J 2003; 21: 95-10
Year: 2003
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Diary–reported symptoms, medication use, and peak expiratory flow (PEF) in an asthma panel in two Swedish cities
Source: Virtual Congress 2021 – Environment and respiratory health
Year: 2021
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept